Q2 Earnings Forecast for ADVM Issued By HC Wainwright
Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) – Equities researchers at HC Wainwright issued their Q2 2025 earnings per share estimates for Adverum Biotechnologies in a note issued to investors on Thursday, May 15th. HC Wainwright analyst M. Caufield expects that the biotechnology company will post earnings per share of ($2.25) for the quarter. HC […]
